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Abstract Glycogen synthase kinase-3 (GSK3) is a key
player in the regulation of neuronal survival. Herein, we
report evidence of an interaction between P2X7 receptors
with NMDA and BDNF receptors at the level of GSK3
signalling and neuroprotection. The activation of these
receptors in granule neurons led to a sustained pattern of
GSK3 phosphorylation that was mainly PKC-dependent.
BDNF was the most potent at inducing GSK3 phosphory-
lation, which was also dependent on PI3K. The P2X7
agonist, BzATP, exhibited additive effects with both
NMDA and BDNF to rescue granule neurons from cell
death induced by PI3K inhibition. This survival effect was
mediated by the PKC-dependent GSK3 pathway. In addi-
tion, ERK1/2 proteins were also involved in BDNF
protective effect. These results show the function of ATP in
amplifying neuroprotective actions of glutamate and neu-
rotrophins, and support the role of GSK3 as an important
convergence point for these survival promoting factors in
granule neurons.
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Introduction
Cerebellar granule neurons provide an excellent model to
study the cellular mechanisms underlying survival and
neuronal maintenance [1]. The actions of several trophic
factors and the intracellular signalling cascades that they
trigger in order to promote neuronal survival is well doc-
umented, as for example IGF-I and BDNF [2]. Recently, in
addition to these well known factors, purine and pyrimidine
nucleotides have been characterised as important extra-
cellular signaling molecules mediating different functions
of physiological relevance in granule neurons. These neu-
rons have been reported to co-express a great diversity of
nucleotide receptors from the ionotropic P2X and metab-
otropic P2Y families [3, 4]. Ionotropic P2X nucleotide
receptors are ligand-operated channels which are coupled
to the entry of extracellular calcium [5]. The metabotropic
P2Y receptors are G-protein coupled receptors mainly
associated with PLC and adenylate cyclase signalling [6].
In previous studies, functional calcium responses have
been demonstrated at the level of rat cerebellar synaptic
terminals and granule cell ﬁbres for P2X1, P2X3, P2X4
and P2X7 receptors [7]. In addition, in rat granule neurons
in culture, P2Y1 receptors have also been shown to be
coupled to increases in the intracellular calcium concen-
tration [3]. Following calcium-related events, several of
these receptors, such as P2Y1, P2X3 and P2X7, were also
shown to induce CaMKII and synapsin I phosphorylation
and subsequent glutamate release in rat granule neurons
[8].
Recent studies have further investigated the intracellular
signalling mechanisms triggered by nucleotide receptors
and have demonstrated the coupling of P2Y13 and P2X7
receptors to GSK3 phosphorylation in rat cerebellar gran-
ule neurons. The activation of both these nucleotide
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levels of GSK3 at speciﬁc Ser residues that were associated
with the inhibition of its catalytic activity [9]. However,
these nucleotide receptors displayed different intracellular
mechanisms to reach GSK3. P2Y13 receptors were coupled
to the well characterized PI3K/Akt dependent pathway,
described for growth factors of the insulin family [10],
resulting in the stabilization of the GSK3 substrate
b-catenin and its translocation to the nucleus, where it
functions as a transcriptional regulator [11]. Nevertheless,
P2X7-induced GSK3 phosphorylation occurred through a
PKC-dependent pathway. This signalling mechanism was
responsible for the protective effect that the P2X7 nucle-
otide agonist, BzATP, exhibited against cell death induced
by the inhibition of the PI3K/Akt survival route [12].
The role of GSK3 as a key regulator of the survival/
apoptosis balance in neurons is supported by a great deal of
evidences [13]. Indeed, over-expression of this protein is
linked to apoptotic cell death in several neuronal models
[14]. Among different potential GSK3 targets, Bax, a
protein of the intrinsic apoptotic cascade that is involved in
mitochondrial pore formation, has been reported to become
phosphorylated and translocated to mitochondria upon
GSK3 activation in granule neurons [15]. In addition,
GSK3 cooperates and contributes to apoptotic signalling,
such as JNK activation, during trophic deprivation [16]. In
this context, several treatments capable of rescuing granule
neurons from low-potassium induced apoptosis, such as
high potassium, IGF-I and cAMP, were described to con-
verge on GSK3 inhibition [17]. What is common for these
factors is that they employ the PI3K/Akt/GSK3-dependent
pathway, and this is deﬁned as the main survival route in
neurons against apoptotic death induced by trophic support
withdrawal [18]. Following the same line of evidence, the
sole expression of the dominant negative GSK3 mutant is
able to rescue cortical neurons from death induced by
serum deprivation [19].
Taking into account the survival effect displayed by the
activation of P2X7 receptors in granule neurons, it is
tempting to speculate that nucleotides could be functioning
as priming molecules either complementing or potentiating
the effects of other survival signals in granule neurons. In
the ﬁrst approach we focused on NMDA, as representative
of activity dependent effects, and BDNF, as representative
of trophic like actions. Although their survival promoting
effects have been well established in this model, their
signalling route to GSK3 has not been deeply characterized
[20]. In the present study, we have found out that NMDA
and BDNF receptors are also coupled to GSK3 phosphor-
ylation in granule neurons through both PKC and PI3K/Akt
dependent mechanisms. We also describe that they are able
to use the PKC/GSK3 pathway to induce neuronal survival
in conditions of PI3K impairment. In the case of BDNF,
ERK proteins are also involved. Additionally, we have also
demonstrated that P2X7 receptors cooperate with both
NMDA and BDNF receptors in promoting neuronal
survival.
Materials and methods
Culture of cerebellar granule neurons
All experiments carried out at the Universidad Complu-
tense de Madrid followed the guidelines of the
International Council for Laboratory Animal Science
(ICLAS). Cerebellar cultures were performed according to
the procedure described by Pons et al. [21]. Cerebella from
Wistar rat pups (P7) were aseptically removed, and sub-
mitted to digestion with papain 100 U/ml (Worthington,
Lake Wood, NJ) (previously activated in EBSS buffer
containing of 5 mM L-Cys, 2 mM EDTA and 0.067 mM
ß-mercaptoethanol), in the presence of 100 U/ml of DNase
(Worthington, Lake Wood, NJ), 1 mM CaCl2 and 1 mM
MgCl2. The obtained cells were resuspended in neurobasal
medium supplemented with B-27 (GIBCO BRL, Paisley,
Renfrewshire, UK) and containing 21 mM KCl, 2 mM
glutamine, and antibiotics, 100 U/ml penicillin, 0.1 mg/ml
streptomycin and 0.25 lg/ml amphotericin B (Sigma–
Aldrich, St Louis, USA), and were plated onto glass
coverslips or plastic Petri dishes (100 mm) (Falcon Becton–
Dickinson Labware, Franklin Lakes, USA) precoated with
0.1 mg/ml poly-L-lysine (Biochrom, AG, Berlin) at a density
of 200,000 cells/cm
2. They were maintained in a humidiﬁed
incubator at 37Ci n5 %C O 2. Ara-C (10 lM) was added to
avoid the proliferation of glial cells.
Cell treatments
Cultured cerebellar granule neurons were used at 9–
11 DIV (days in vitro). In the experiments regarding GSK3
phosphorylation, prior to the stimulation of cells with the
different effectors, cells were routinely washed for about
2 h at 37C in a low potassium medium [Locke solution, in
mM: NaCl, 140; KCl, 4.7; CaCl2, 2.5; KH2PO4, 1.2;
MgSO4, 1.2; glucose, 5.5; and HEPES (acid), 10; pH 7.4]
in order to lower the basal levels of GSK3 and ERK1/2
phosphorylation, which are normally elevated as a conse-
quence of the high potassium medium. After this washing
period, the medium was again replaced by normal Locke
solution in the case of BDNF, or by Locke solution in the
absence of Mg
2?, in the case of BzATP and NMDA, and
then the corresponding agents were added at the required
concentrations for the required incubation times. Mg
2?-
free medium was used in order to enhance P2X7 and
NMDA-mediated responses, as both receptors are known to
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and BDNF were assayed at maximal saturating concen-
trations of 300 lM and 50 ng/ml, respectively.
Nevertheless, in the case of NMDA, a submaximal con-
centration of 50 lM was preferred over 100 lM, in order
to avoid possible excitotoxic actions.
Survival studies required long-term periods, and in this
case, the treatments were applied in complete culture
medium. BzATP, NMDA and BDNF were added 10 min
before the addition of the PI3K inhibitor LY-294002. Cell
viability was then evaluated 24 h later. When receptor
antagonists and transducing inhibitors were employed, they
were added 10 or 20 min before the agonists.
Western blot experiments
Cells were stimulated in the presence of the nucleotide
agonists and IGF-I with different treatments for the
required times. Stimulation was stopped by addition of
lysis buffer that consisted of: 20 mM MOPS, 50 mM NaF,
40 mM b-glycerophosphate, 1 mM sodium orthovanadate,
5 mM EDTA, 2 mM EGTA, 0.5% Triton X-100, pH 7.2,
1 mM PMSF and protease inhibitor cocktail (Complete,
Roche). Protein determination of the cell extracts was
performed and then mixed with sample buffer 49 (50%
Glycerol, 125 mM Tris pH 6.8, 4% SDS, 1% bromophenol
blue, 5% b-mercaptoetanol, 4,5% H2O). The samples
(25 lg protein) were heated at 99C and aliquots were
subjected to sodium dodecyl sulfate (SDS) gel electro-
phoresis (25 mM Tris, 200 mM glycine, 0.1% SDS, pH
8.3) using 12% acrylamide gels. Immunotransference was
performed on PVDF membranes (Amersham Biosciences
Europe GmbH, Barcelona, Spain) (25 mM Tris, 192 mM
glycine, 20% methanol). The TBS buffer (100 mM NaCl,
10 mM Tris–HCl, pH 7.5) containing 1% (v/v) Tween-20
and 5% BSA was employed as a blocking medium and was
used in subsequent incubations with the antibodies. Incu-
bation with the antibodies was performed at the following
dilutions: 1:750 for phospho-GSK3 a/b (Ser21/9), caspase-
3, b-III tubulin (all of them from Cell Signalling Tech-
nology, Beverly, MA, USA), and 1:1,000 for total GSK3
(Biosource, Nivelles, Belgium), phospho-ERK1/2 (Thr202/
Tyr204), total ERK (Santa Cruz Biotechnologies Inc.,
Santa Cruz, CA, USA). Primary antibodies were detected
with horseradish peroxidase-conjugated antibodies, 1:4,000
for anti-mouse (Santa Cruz Biotechnology Inc., Santa
Cruz, CA) and 1:4,000 for anti-rabbit (Jackson Immuno-
Research Laboratories, West Grove, PA, USA), and
visualized by the ECL method (kit Super Signal substrate
Wester Blotting, from Amersham Biosciences Europe
GmbH, Barcelona, Spain). The chemiluminscence images
were quantiﬁed by densitometry employing the Fluo-S
Imager, Bio-Rad (Munich, Germany).
Cell viability assays
Neuronal survival was assayed by both LIVE/DEAD via-
bility/cytotoxicity kit (Molecular Probes) and MTT assay.
The LIVE/DEAD viability/cytotoxicity assay was applied
after the corresponding treatment with LY-294002. This
measures the number of live cells that have incorporated
the green ﬂuorescent calcein dye versus the number of dead
cells, which have incorporated the red ethidium dye
(ethidium homodimer-1). The immunoﬂuorescence pic-
tures were taken with a Nikon TE-200 microscope and a
Kappa DX2 camera controlled by Kappa Image Base
Control software.
In the MTT assay the mitochondrial function is assessed.
This method employed MTT tetrasodium salt [3-(4,5-
dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide]
(Sigma), which was added to the cultures after the LY-
294002 treatment, at a ﬁnal concentration of 0.5 mg/ml,
and was maintained for 2 h at 37C. Then, an equal volume
of MTT solubilization solution (10% Triton X-100 plus
0.1 N HCl in anhydrous isopropanol) was added, following
a brief incubation of 30 min at room temperature with
orbital shaking. The samples were collected and measured
spectrophotometrically at 570 nm. Values were normalized
with respect to that obtained from untreated cells, consid-
ered as 100% survival.
Statistical analysis
Data are represented as mean ± SD of at least three
independent experiments obtained from different cultures.
Comparison between different treatments and controls
were carried out using Dunnett’s test, and comparisons
between different samples were performed using Tukey’s
test. A probability of \0.05 was considered signiﬁcant.
Data were statistically signiﬁcant at ***/###P\0.001,
**/##P\0.01 and */#P\0.05.
Results
BzATP, NMDA and BDNF are coupled to GSK3
phosphorylation in cerebellar granule neurons
Phosphorylation of GSK3 at Ser
21 and Ser
9 residues for a
and b isoforms, respectively, can be taken as indicative of
its inhibition level, and can be evaluated with speciﬁc
antibodies against the phorphorylated forms. In a previous
work, the effect of several nucleotidic agonists on GSK3
phosphorylation was investigated, and among them,
BzATP resulted to be the most potent, through the
activation of the P2X7 nucleotide receptor. We demon-
strated that BzATP-induced GSK3 phosphorylation was
P2X7, NMDA and BDNF cooperation 1725dependent on extracellular calcium, and sensitive to P2X7
speciﬁc antagonists [12]. In the present study the effect of
BzATP on GSK3 phosphorylation was compared to other
relevant extracellular signals in granule neurons, such as
glutamate and BDNF.
As can be seen in Fig. 1A, BzATP (300 lM), NMDA
(50 lM) and BDNF (50 ng/ml) were able to induce sig-
niﬁcant increases in GSK3 phosphorylation over basal
levels. They exhibited a similar time-dependent pattern, as
GSK3 phosphorylation was sustained over 1–2 h of stim-
ulation periods with the three stimuli. BDNF was the
fastest and most potent signal, producing the highest levels
of GSK3 phosphorylation at as early as 5 min of stimula-
tion. This agrees with the rapid BDNF-mediated signalling
reported in granule and hippocampal neurons [22]. In the
case of NMDA and BzATP the increase percentages in
GSK3 phosphorylation were in the same range, being
always slightly higher for NMDA.
In subsequent experiments we analyzed in more detail
the intracellular signalling mechanism of GSK3 phos-
phorylation induced by the three stimuli, employing
inhibitors of different signal transducing proteins that can
be upstream of GSK3. Taking into account that PI3K/Akt
is very important in the signalling elicited by both NMDA
and BDNF, this pathway was selectively blocked by the
treatment with the speciﬁc inhibitor LY-294002. As
expected, LY-294002 (50 lM, 20 min) was able to abolish
BDNF-induced increase in GSK3 phosphorylation, but
only partially affected the BzATP and NMDA-mediated
effects (Fig. 1b).
In accordance with the mechanism of action of TrkB
receptors activated by BDNF in granule neurons, the pre-
treatment with Go ¨ 6976 (0.5 lM, 20 min), an inhibitor of
the calcium-dependent PKC subtypes, eliminated BDNF-
mediated responses. PKC inhibition also blocked the
BzATP-mediated increase in GSK3 phosphorylation, but a
residual effect seemed to persist after NMDA stimulation.
Finally, we assessed the role of the MAPK pathway in
GSK3 regulation using U-0126 (10 lM, 20 min), an
inhibitor of MEK-1 that is upstream ERK1/2. These pro-
teins did not affect the increase in GSK3 phosphorylation
levels induced by BzATP, NMDA or BDNF (Fig. 1b).
To substantiate the calcium dependence of GSK3 inhi-
bition displayed by the effectors, other strategies were
tested. When extracellular calcium was chelated by a
mixture of EGTA/Tris, BzATP and NMDA-induced GSK3
phosphorylation was totally abrogated, as expected for the
ionotropic nature of the receptors, P2X7 and NMDA
receptors. In addition, intracellular calcium quelation by
BAPTA also abolished BDNF-mediated effect (Supple-
mentary Fig. 1A). These results support the involvement of
classical calcium-dependent PKC isoforms, probably
PKCa and PKCb1, which are the predominant subtypes
expressed in cultured granule neurons at this stage of dif-
ferentiation [23].
P2X7 and NMDA receptors converge on GSK3
phosphorylation in granule neurons
The above results indicate that some differences are clear
among the factors analyzed with respect to the signalling
Fig. 1 GSK3 phosphorylation induced by BzATP, NMDA and
BDNF in granule neurons. a Time-course of GSK3 phosphorylation.
Granule cells were stimulated with 300 lM BzATP, 50 lM NMDA
and 50 ng/ml BDNF, at different incubation times. b Effect of various
signalling pathway inhibitors on GSK3 phosphorylation. Granule
cells in culture were submitted to different treatments: 20 min
incubation with signalling inhibitors, 50 lM LY-294002, 0.5 lMG o ¨
6976 and 10 lM U-0126. Then cells were stimulated for 10 min with
300 lM BzATP, 50 lM NMDA and 50 ng/ml BDNF in the
continuous presence of these inhibitors. Then cells were harvested
and phosphorylation of GSK3 was analysed by immunoblotting.
Histograms represent the percentage increase with respect to non-
stimulated cells (100% control value), and were obtained by
normalization of densitometric values of phospho-proteins with
respect to total forms of GSK3. The blots correspond to representative
experiments and values are the mean ± SD of at least three
experiments performed from different cultures. Data were analysed
by Dunnet and Tukey tests, and were statistically signiﬁcant at
*P\0.05 and ***P\0.01 when the effects were compared to the
respective control for each condition (open bars in the absence
stimulation)
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possibility of additive effects upon co-stimulation. Fig-
ure 2a shows the dose–response curve for NMDA-induced
GSK3 phosphorylation performed in the absence and
presence of co-stimulation with the nucleotide agonist
BzATP. It can be observed that when suboptimal concen-
trations of both effectors were added together, the levels of
GSK3 phosphorylation were higher with respect to that
obtained with either BzATP or NMDA alone. This is in
agreement with BzATP and NMDA converging on the
same PKC/GSK3 dependent pathway. Similar studies car-
ried out with BzATP and BDNF did not shown any
cooperation on GKS3 phosphorylation, even using
submaximal BDNF concentrations (0.5 ng/ml) (Supple-
mentary Fig. 2).
Therefore, it can be concluded that BzATP is potenti-
ating the effect of NMDA on GSK3 phosphorylation in
granule neurons. In order to assess the speciﬁcity of the
effects, the NMDA speciﬁc receptor antagonist, D-AP5
(10 lM), was employed, and as shown in Fig. 2b, this
treatment signiﬁcantly affected NMDA-mediated respon-
ses. In the case of the BDNF receptor, a kinase inhibitor of
Trk type receptors was used, K-252a (100 nM), which
partially blocked the effect of NMDA, but not that of
BzATP. These results conﬁrm that, although Trk activity
seems to partially contribute to NMDA-mediated response,
it has no effect on BzATP response.
BzATP cooperates with NMDA and BDNF
in promoting granule cell survival against PI3K
pharmacological inhibition
The coupling of BzATP, NMDA and BDNF to GSK3
regulation led us to investigate the physiological meaning
of this signalling mechanism. In fact, GSK3 has been
reported to play a major role in cell death induced by
trophic withdrawal, an apoptotic outcome that can be
reproduced by the blockade of the PI3K/Akt axis. By using
this approach, we have tested the possible neuroprotective
role of these agents. In addition to BzATP, NMDA and
BDNF were able to elicit survival in conditions of sus-
tained PI3K inactivation with the inhibitor LY-294002
(50 lM) (Fig. 3a, b). This indicated that, although NMDA
and BDNF receptors are coupled to PI3K/Akt signalling,
they can by-pass the PI3K/Akt axis and display alternative
survival routes. NMDA resulted to be always more effec-
tive than BzATP and BDNF in promoting granule cell
survival, as survival levels with NMDA reached about
Fig. 2 Convergence of BzATP and NMDA in GSK3 phosphoryla-
tion. a Effect of combined treatment of BzATP and NMDA on GSK3
phosphorylation. Granule neurons were stimulated for 10 min with
different NMDA concentrations (from 0.1 to 100 lM) in the absence
or presence of co-stimulation with 100 lM BzATP concentration.
b Effect of NMDA antagonist and kinase inhibitor of TrkB receptor.
Cells were treated for 5 min with 10 lM D-AP5 and 100 nM K-252a,
and then 300 lM BzATP, 50 lM NMDA and 50 ng/ml BDNF were
added for additional 10 min. Then cells were harvested and
phosphorylation of GSK3 was analysed by immunoblotting, as
described in ‘‘Material and methods’’. Data were obtained by
normalization of densitometric values of phospho-GSK3 with respect
to total GSK3. The blots correspond to representative experiments
and values are the mean ± SD of at least three experiments
performed from different cultures. Data were analysed by Dunnet
and Tukey tests, and were statistically signiﬁcant at ***P\0.001
and **P\0.01 when the effects were compared to the controls
(empty bars in the absence stimulation) (a, b), and at
###P\0.001,
and
#P\0.05, when the values at each NMDA concentration was
compared in the absence and presence of BzATP a. Bz BzATP,
N NMDA, BD BDNF
b
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the same range of around 30–35% (Fig. 3b). It is inter-
esting to notice that the use of the TrkB kinase inhibitor,
K-252a, was only able to eliminate the protection elicited
by BDNF, but not that induced by BzATP or NMDA,
giving evidence that the neuroprotective effect mediated by
BzATP and NMDA did not occur through TrkB receptor
transactivation.
Importantly, we have also found that the pre-treatment
with the PKC inhibitor Go ¨ 6976 compromised the survival
effects of BzATP, NMDA and specially that induced by
BDNF, supporting the involvement of cPKC isoforms in
the intracellular signalling triggered by these stimuli
(Fig. 3b). Interestingly, BDNF protective effect resulted to
be also dependent on MAPKs, as the MEK-1 inhibitor,
U-0126, abolished the effect of BDNF without affecting
responses to BzATP and NMDA.
The involvement of calcium dependent PKC isoforms in
the survival effects were also corroborated by studying
their calcium dependence (Supplementary Fig. 1B). Che-
lating extracellular calcium with EGTA/Tris completely
abolished BzATP and NMDA protective effects. The same
was obtained when the effect of BDNF was analyzed in the
presence of BAPTA (Supplementary Fig. 1B).
Considering that none of the three stimuli was able to
elicit a complete recovery on neuronal survival, one could
anticipate that some cooperative or additive effects could
be observed when these factors were acting together. As
expected, co-stimulation with BzATP was able to increase
the survival levels at every NMDA and BDNF concentra-
tions (Fig. 3c), adding up their individual survival effects.
GSK3 is involved in the survival promoting effect
of BzATP, NMDA and BDNF in granule neurons
The next set of experiments was conducted in order to
corroborate the involvement of BzATP, NMDA and
BDNF-induced GSK3 signalling in their survival promot-
ing actions against PI3K inhibition. GSK3 phosphorylation
levels were evaluated after 6 h exposure to the PI3K
inhibitor LY-294002 (50 lM). As shown in Fig. 4a, gran-
ule neurons in complete culture media exhibited high levels
of basal GSK3 phosphorylation, which were almost com-
pletely lost after 6 h treatment with the PI3K inhibitor. Pre-
treatment with the survival factors BzATP, NMDA and
BDNF was able to partially reverse the loss in GSK3
phosphorylation levels, being BDNF the most potent in
inducing this effect. Considering that BzATP was able to
Fig. 3 Effect of BzATP, NMDA and BDNF in the regulation of
neuronal survival in viability assays. The different treatments were
added directly to granule neurons maintained in complete culture
medium. The PI3K inhibitor, LY-294002, was added at 50 lM
concentration, and cell viability was analyzed 24 h later by the LIVE/
DEAD viability/cytotoxicity kit a and the MTT assay (b, c).
a, b Survival effects of BzATP, NMDA and BDNF. In a granule
neurons were stimulated in the absence (control) or presence of
300 lM BzATP for 10 min, before the addition of LY-294002, except
in the control. The micrographs show the same ﬁeld in visible (upper
panels) and calcein/ethidium bromide staining (lower panels). The
apoptotic nuclei are stained red, and viable cells are stained green.
b Schematic representation of the experimental design followed in
survival studies. Granule neurons were preincubated in the absence
and presence of the kinase inhibitors: 200 nM K-252a, 0.5 lMG o ¨
6976 and 10 lM U-0126 for 20 min previous to the addition of the
agonists, 300 lM BzATP, 50 lM NMDA and 50 ng/ml BDNF. After
10 min, the PI3K inhibitor LY-294002 was added and cell viability
tested 24 h later. c Additive survival effects of BzATP with NMDA
and BDNF. The following stimulations were done before the addition
of LY-294002: 100 and 300 lM BzATP, 5, 50 and 100 lM of NMDA,
and 0.5, 5 and 50 ng/ml BDNF. The stimulations with NMDA and
BDNF were carried out in the absence or presence of co-stimulation
with 300 lM BzATP (dark grey bars). Data are the mean ± SD of at
least three experiments performed in duplicate from different cultures.
Data were analysed by Dunnet and Tukey tests and were statistically
signiﬁcant at ***P\0.001, **P\0.01 and *P\0.05 when treat-
ments with LY-294002 (dashed bars in b and c) were taken as
reference, and at ##P\0.001 and #P\0.05 when each value was
compared in the presence or absence of BzATP (dark grey bars). LY
LY-294002, Bz BzATP, N NMDA, BD BDNF
b
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increase in the recovery of GSK3 phosphorylation levels
was observed when these two factors were combined,
which was not easy to observe with BDNF, due to its
robust response (Fig. 4a, b). These results indicate that
BzATP, as well as NMDA and BDNF, were able to rescue
granule neurons against PI3K blockade by a mechanism
that involves GSK3 inhibition. Interestingly, although
ERK1/2 did not vary signiﬁcantly after LY-294002 treat-
ment, BDNF was the only survival factor able to induce a
further increase in ERK1/2 phosphorylation levels, sug-
gesting that MAPKs were also involved in the survival
signalling mechanism mediated by BDNF (Fig. 4a, c).
The cooperation of BzATP with NMDA and BDNF was
also reproduced at the level of the apoptotic inducer cas-
pase-3. The appearance of the 17-kb active caspase-3
fragment was clearly reversed by incubation with BzATP,
NMDA and BDNF, being this reversion stronger upon the
combination of BzATP with both NMDA and BDNF
(Fig. 4a, d).
A series of experiments was performed in order to fur-
ther conﬁrm the intracellular signalling requirements for
BzATP, NMDA and BDNF involved in their survival
effect against PI3K inhibition. Figure 5 show that pre-
treatment with the PKC inhibitor Go ¨ 6976 did not alter the
loss in GSK3 phosphorylation levels induced by the PI3K
inhibitor, but totally prevented the recovery mediated by
BzATP, NMDA and BDNF. Pre-treatment with the MAPK
inhibitor, U-0126, was also able to diminish BDNF-
induced recovery in the levels of GSK3 phosphorylation
(Fig. 5c). These results taken together further corroborate
that BzATP, as well as NMDA and BDNF, were able to
rescue granule neurons against PI3K blockade by a
mechanism that involves GSK3 inhibition. In addition,
MAPKs were also involved in the survival signalling
mechanism triggered by BDNF (Fig. 6).
Discussion
The present study supports the role of nucleotides as rel-
evant physiological signals in granule neurons amplifying
the neuroprotective actions of key trophic and survival
stimuli in these cells, such as glutamate and BDNF. The
Fig. 4 Analysis of the effect of LY-294002 treatment on phosphor-
ylation levels of GSK3 and ERK1/2, and caspase-3 activation.
Granule neurons maintained in complete culture medium were treated
in the presence or absence of 300 lM BzATP, 50 lM NMDA and
50 ng/ml BDNF for 10 min before the addition of 50 lM LY-294002.
Cell extracts were obtained at 6 h incubation time with LY-294002
treatment and analysed by immunoblotting for GSK3 and ERK1/2
phosphorylation (a–c), and for the presence of the 17 kDa active
caspase-3 fragment (a, d). Histograms represent the percentage
increase with respect to non-stimulated cells (100% control value),
and were obtained by normalization of densitometric values of
phospho-proteins and caspase-3, with respect to that obtained for
b-tubulin, employed as a control charge. Values are the mean ± SD
of at least three experiments performed from different cultures. The
blots correspond to representative experiments a. Data were analysed
by Dunnet and Tukey tests and were statistically signiﬁcant at
***P\0.001, **P\0.01 and *P\0.05 when compared to the
control of untreated cells (empty bars), and at
###P\0.001,
##P\0.01 and
#P\0.05, when compared with LY-294002 treat-
ment (dashed bars), as indicated in the ﬁgure. LY LY-294002,
Bz BzATP, N NMDA, BD BDNF
P2X7, NMDA and BDNF cooperation 1729point of convergence for the additive survival effects
between the activation of P2X7 receptors and NMDA or
BDNF (TrkB) receptors appears to be phosphorylation of
GSK3. The coupling of BzATP, NMDA and BDNF to
GSK3 phosphorylation and inhibition explains the neuro-
protective effects that they exert against apoptosis induced
by PI3K inhibition, which mimics conditions of trophic
deprivation. In addition to the well documented functions
of BDNF and NMDA in granule neurons [24, 25]
the present work is the ﬁrst attempt to examine in depth
the coupling of these factors to GSK3. Therefore, our
data provide evidence that GSK3 is an important and
generalized signalling target for different unrelated physi-
ologically relevant stimuli in granule neurons including
trophic factors, such as BDNF, to rapidly diffusible
extracellular signals, such as ATP.
The cooperation observed for BzATP on NMDA-med-
iated responses occurs at the level of both GSK3
phosphorylation and neuroprotection. Although NMDA
has been described to be strongly coupled to the PI3K/Akt
axis in granule and cortical neurons [20, 24, 26], this does
not seem to be the main pathway for GSK3. From the
present results it is clear that the full effect of NMDA-
receptor activation on GSK3 phosphorylation is obtained
Fig. 5 Effect of PKC and MAPK inhibition on GSK3 phosphoryla-
tion levels under conditions of PI3K inhibition. Granule neurons
maintained in complete culture medium were treated in the presence
or absence of 300 lM BzATP, 50 lM NMDA and 50 ng/ml BDNF
for 10 min before the addition of 50 lM LY-294002. When required,
the transducing inhibitors, 0.5 lMG o ¨ 6976 and 10 lM U-0126 were
added for 20 min before the addition of the three stimuli. Cell extracts
were obtained at different incubation times of 1, 3 and 6 h with
LY-294002 treatment, and analysed by immunoblotting for GSK3
phosphorylation, as described before. In a the blots corresponding to
representative experiments are shown. In b the phosphorylation
values for BzATP and NMDA treatments are shown, and in c for
BDNF. Values are the mean ± SD of at least three experiments
performed from different cultures. Data were analysed by Dunnet and
Tukey tests, and were statistically signiﬁcant at
###P\0.001,
##P\0.01 and
#P\0.05, when the values at each LY-294002
incubation time were compared with respect to the treatments with Go ¨
6976 and U-0126. LY LY-294002, Bz BzATP, N NMDA, BD BDNF
Fig. 6 Schematic diagram of P2X7, NMDA and TrkB receptors
coupling to GSK3 signalling through different routes in cerebellar
granule neurons. P2X7, NMDA and TrkB receptors trigger different
intracellular pathways to induce GSK3 phosphorylation and elicit
neuroprotection in granule neurons. P2X7 and NMDA ionotropic
receptors are both coupled to the entry of extracellular calcium and
share the same PKC-dependent route to provoke GSK3 phosphory-
lation and neuroprotection. BDNF receptor signalling is mainly
coupled to the PI3K/Akt axis in a PLC/PKC-dependent manner.
When PI3K is inactivated, BDNF then uses an alternative route
through the activation of the ERK1/2 proteins to maintain GSK3
inhibition and elicit survival
1730 F. Ortega et al.primarily through a PKC-dependent pathway, in the same
way that BzATP acting through P2X7 receptors. This is the
reason why NMDA is able to rescue granule neurons from
apoptosis induced by PI3K inhibition with LY-294002.
Therefore, the convergence of BzATP and NMDA onto the
same PKC-dependent pathway explains that their effects
result additive when both signals are present at suboptimal
concentrations (Fig. 6). The sum of effects shown for
BzATP and NMDA in granule neurons indicates a new and
interesting example of interaction between P2X7 and
NMDA receptors. The different approaches used revealed
that calcium-dependent PKC isoforms were responsible for
the GSK3 phosphorylation and the neuroprotective effects
displayed by the three effectors, which could corresponded
to PKCa and PKCb subtypes [23].
The cooperation between BzATP and BDNF was clearly
assessed at the level of the survival promoting effect
against the sustained PI3K inhibition. BDNF neuroprotec-
tive effect depends on different signalling mechanisms that
involve both GSK3 and ERK proteins, and these effects are
additive to those displayed by BzATP, even when both
factors are present at maximal concentrations. Thus, they
will be acting on different intracellular targets to stop the
activation of the apoptotic machinery. BDNF has been
reported to activate transcription factors, such as CREB
and NFjB, in an ERK-dependent fashion, and to increase
the expression of anti-apoptotic genes of the bcl-2 family
[24]. In granule neurons, the protein Bax has been descri-
bed to be phosphorylated by GSK3, and this could be one
possible target for P2X7 receptors [15].
Another interesting point to examine in more detail is
the signalling mechanism elicited by BDNF in granule
neurons. Our results support a key role for PKC as a
common upstream effector of both GSK3 and ERK path-
ways activated by BDNF (Fig. 6). This is in agreement to
that reported for TrkB receptor activation in cortical and
granule neurons, which is primarily coupled to PLCc
phosphorylation and the subsequent activation of cPKC.
From cPKC, two pathways are separated, leading either to
ERK activation through the intermediate Ras, or to acti-
vation of the PI3K/Akt axis [27]. It appears that these
branching routes are independent, as GSK3 phosphoryla-
tion, but not ERK1/2, is completely dependent on the
PI3K/Akt axis. Furthermore, GSK3 phosphorylation med-
iated by BDNF seems to be unaffected by MAPK
inhibition. Nevertheless, the survival studies carried out in
the present work provide evidence that some degree of
cross-talk is taking place, and that it can be triggered when
changing the environmental conditions. Indeed, BDNF-
stimulated GSK3 phosphorylation and neuroprotection
becomes MAPK-dependent only when the PI3K/Akt axis is
impaired. Therefore this is pointing to ERK proteins as an
alternative route reaching to GSK3. In agreement with our
present results, studies performed in cortical neurons have
reported that both NMDA and BDNF can alternatively use
the ERK route as the survival mechanism to compensate
for the loss of PI3K activity. Although in this case,
ERK-mediated inhibition of GSK3 catalytic activity was
occurring through a mechanism different to GSK3 phos-
phorylation events and that could involve the complex
formation between the two proteins [28]. This is different
to that seen in our results, as BDNF-mediated neuropro-
tection involved GSK3 phosphorylation in an ERK-
dependent way. In this respect, p90
rsk (RSKs) has been
described as the candidate upstream kinase for GSK3
phosphorylation in Ser residues after the assembly and
priming of GSK3 with ERK1/2 proteins [29]. Therefore, it
cannot be excluded that a similar mechanism of interplay
between GSK3 and ERK proteins could be taking place in
granule neurons.
The versatility of BDNF as a survival factor is further
supported by other examples in which this neurotrophin is
capable of discriminating between different signalling
routes depending on the type of noxious stimuli. When all
the intracellular cascades are fully functional, BDNF
preferentially uses the PI3K/Akt route to protect against
trophic factor deprivation, and alternatively uses ERK
signalling to protect against DNA damaging agents [25].
Finally, it is interesting to consider and emphasize the
possible physiological implications of the cooperation
described in the present study between different kinds of
extracellular signals, such as ATP with glutamate and
BDNF. This kind of interactions could have a relevant
special meaning taking into account that these factors are
part of a reinforcement survival mechanism that operates in
granule and hippocampal neurons [24]. Many of the
NMDA protective actions are attributed to BDNF secre-
tion, which then activates TrkB receptors on this neuron
itself or on surrounding neurons to elicit survival respon-
ses. Indeed, the intracellular signals activated by NMDA,
such as ERK and Akt, are partially dependent on TrkB
activation, as also observed for GSK3 signalling in the
present study [30]. Although many examples exist in the
literature concerning P2Y nucleotide receptors interacting
with neurotrophins [31], our results with P2X7 receptors in
granule neurons give evidence that releasing mechanisms
or TrkB transactivating effects are not contributing to the
observed BzATP-mediated neuroprotection. Nevertheless,
it cannot be excluded that this type of cross-mechanisms
could take place in more physiological conditions, taking
into account that some precedents are found in recent
interesting works regarding the effect of nucleotide
receptors in both BDNF expression and release. In relation
to this, P2X7 receptors are responsible for BDNF release
from Schwann cells, which display neuroprotective actions
on neighbouring vestibular neurons [32]. In activated
P2X7, NMDA and BDNF cooperation 1731microglia, P2X4 is up-regulated and promotes BDNF
release in spinal cord neurons contributing to pain signal-
ling [33]. In addition, ATP is reported to induce BDNF
gene expression in cortical astrocytes acting through a
P2Y1 receptor, an effect involving CaMKII activation and
CREB-induced transcription [34].
As observed in the present studies, there is growing
evidence that ATP and nucleotides are becoming important
priming molecules able to interact with other extracellular
signals to amplify or modulate their signalling and survival
actions in neurones [35]. These actions could be of special
relevance under conditions in which trophic support is
being compromised, as for example, in some inﬂammatory
and neurodegenerative insults. Whether nucleotides can
participate in the NMDA-BDNF loop in granule neurons is
the aim of future work and could open a new dimension in
the potential protective role of nucleotides in the nervous
system.
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